These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9302749)

  • 1. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host.
    Bastien N; Taylor G; Thomas LH; Wyld SG; Simard C; Trudel M
    Vaccine; 1997; 15(12-13):1385-90. PubMed ID: 9302749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
    Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
    Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
    Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines.
    Bastien N; Trudel M; Simard C
    Vaccine; 1999 Feb; 17(7-8):832-6. PubMed ID: 10067688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.
    Schmidt U; Beyer J; Polster U; Gershwin LJ; Buchholz UJ
    J Virol; 2002 Dec; 76(23):12355-9. PubMed ID: 12414977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunobiology of bovine respiratory syncytial virus infections].
    Schrijver RS
    Tijdschr Diergeneeskd; 1998 Nov; 123(22):658-62. PubMed ID: 9836385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses against epitopes on the F protein of bovine respiratory syncytial virus differ in infected or vaccinated cattle.
    Schrijver RS; Hensen EJ; Langedijk JP; Daus F; Middel WG; Kramps JA; van Oirschot JT
    Arch Virol; 1997; 142(11):2195-210. PubMed ID: 9672586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection.
    Simard C; Nadon F; Séguin C; Trudel M
    Antiviral Res; 1995 Dec; 28(4):303-15. PubMed ID: 8669890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
    Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
    J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine respiratory syncytial virus-specific immune responses in calves after inoculation with commercially available vaccines.
    Ellis JA; Hassard LE; Morley PS
    J Am Vet Med Assoc; 1995 Feb; 206(3):354-61. PubMed ID: 7751246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bovine respiratory syncytial virus strain with mutations in subgroup-specific antigenic domains of the G protein induces partial heterologous protection in cattle.
    Schrijver RS; Langedijk JP; Middel WG; Kramps JA; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1998 Oct; 63(2-4):159-75. PubMed ID: 9850996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of rapid human respiratory syncytial virus strip tests for detection of bovine respiratory syncytial virus in experimentally vaccinated calves.
    Socha W; Rola J
    Pol J Vet Sci; 2012; 15(4):629-34. PubMed ID: 23390751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.